Ashland Q4 Earnings Miss Estimates on Portfolio Actions, Revenues Down

06.11.25 13:12 Uhr

Werte in diesem Artikel

Ashland Global Holdings Inc. ASH recorded a profit of $32 million or 71 cents per share for the fourth-quarter fiscal 2025 (ended Sept. 30, 2025) compared with a profit of $16 million or 33 cents in the prior-year quarter. Barring one-time items, adjusted earnings were $1.08 per share, down from the year-ago quarter figure of $1.26. The bottom line missed the Zacks Consensus Estimate of $1.17. Sales were down 8% year over year to $478 million. The top line beat the Zacks Consensus Estimate of $474 million. Sales for the fiscal fourth quarter were adversely impacted by the portfolio optimization actions involving curtailing or divesting certain lower-margin products, lower volumes in Specialty Additives and reduced pricing. Ashland Inc. Price, Consensus and EPS Surprise Ashland Inc. price-consensus-eps-surprise-chart | Ashland Inc. QuoteASH’s Segment HighlightsLife Sciences: Sales in the segment were down 10% year over year to $173 million in the reported quarter. The Zacks Consensus Estimate for the same was $172 million. The decline was primarily caused by the portfolio optimization. Personal Care: Sales in the division declined 7% year over year to $151 million. The metric surpassed the Zacks Consensus Estimate of $148 million. The decrease was primarily due to portfolio optimization, mainly attributed to the divestiture of the Avoca business line. Specialty Additives: Sales in the segment fell 9% year over year to $131 million but beat the Zacks Consensus Estimate of $129 million. The decline was primarily due to the portfolio actions, including the divestment of the low-margin construction business. Intermediates: Sales in the segment went down 8% year over year to $33 million. The figure also missed the consensus estimate of $34 million. Overall sales decreased, mostly due to lower prices and reduced merchant volumes. ASH’s FinancialsCash and cash equivalents were $215 million at the end of the quarter, up around 3.9% sequentially. Long-term debt was $1,384 million, up roughly 2.6% over the prior quarter. ASH’s OutlookFor fiscal 2026, Ashland expects sales to be in the range of $1.835-$1.905 billion and adjusted EBITDA to be $400-$430 million. ASH’s Price PerformanceShares of Ashland have lost 37.1% in the past year compared with a 12.7% decline in the industry. Image Source: Zacks Investment ResearchASH’s Zacks Rank & Key PicksASH currently carries a Zacks Rank #5 (Strong Sell). Some better-ranked stocks worth a look in the basic materials space are AngloGold Ashanti plc AU, Integra Resources Corp. ITRG and U.S. Gold Corp. USAU. AngloGold is scheduled to report third-quarter results on Nov. 11. AU carries a Zacks Rank #1 (Strong Buy) at present. The Zacks Consensus Estimate for AU’s third-quarter earnings is pegged at $1.34, indicating a 139.3% year-over-year growth. You can see the complete list of today’s Zacks #1 Rank stocks here.Integra Resources is scheduled to report third-quarter results on Nov. 12. ITRG carries a Zacks Rank #2 at present. The consensus estimate for ITRG’s third-quarter earnings is pegged at 13 cents, indicating a 262.5% year-over-year growth. U.S. Gold is expected to report fiscal second-quarter results on Dec. 15. USAU carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for USAU’s second-quarter earnings is pegged at a loss of 13 cents, indicating a 35% year-over-year growth.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ashland Inc. (ASH): Free Stock Analysis Report AngloGold Ashanti PLC (AU): Free Stock Analysis Report US Gold Corp (USAU): Free Stock Analysis Report Integra Resources Corp. (ITRG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Ashland Global und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Ashland Global

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ashland Global

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ashland Global Holdings Inc

Wer­bung

Analysen zu Ashland Global Holdings Inc

DatumRatingAnalyst
29.03.2018Ashland Global OutperformBMO Capital Markets
31.01.2018Ashland Global NeutralMonness, Crespi, Hardt & Co.
16.05.2017Ashland Global BuyMonness, Crespi, Hardt & Co.
28.11.2016Ashland BuyDeutsche Bank AG
27.01.2016Ashland BuyMonness, Crespi, Hardt & Co.
DatumRatingAnalyst
29.03.2018Ashland Global OutperformBMO Capital Markets
16.05.2017Ashland Global BuyMonness, Crespi, Hardt & Co.
28.11.2016Ashland BuyDeutsche Bank AG
27.01.2016Ashland BuyMonness, Crespi, Hardt & Co.
23.09.2015Ashland BuyDeutsche Bank AG
DatumRatingAnalyst
31.01.2018Ashland Global NeutralMonness, Crespi, Hardt & Co.
04.01.2007Update Ashland Inc.: HoldMatrix Research
03.01.2007Update Ashland Inc.: HoldKeyBanc Capital Markets / McDonald
05.12.2006Update Ashland Inc.: NeutralJP Morgan
15.11.2006Update Ashland Inc.: NeutralCredit Suisse
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ashland Global Holdings Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen